Bezafibrate Retards The Progression Of Coronary Atherosclerosis Mainly In Mild To Moderate Lesions. Results Of Further Analyses Of The Bezafibrate Coronary Atherosclerosis Intervention Trial (Becait)
CIRCULATION（1996）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined